Brief: Matinas Biopharma Says MAT9001 Contract Manufacturer Suffered Explosion At Asia Manufacturing Facilities
28/12/2020 11:58
Dec 28 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A :
* MATINAS BIOPHARMA - BECAME AWARE THAT A CONTRACT
MANUFACTURER OF
MAT9001 SUFFERED EXPLOSION AT ITS MANUFACTURING FACILITIES IN
ASIA
* MATINAS BIOPHARMA HOLDINGS INC - NONE OF COMPANY'S KEY
OMEGA-3
INTERMEDIATES STORED AT FACILITY WERE DAMAGED OR DESTROYED
Source text: [ID: https://bit.ly/2L1gYiy]
Further company coverage: MTNB.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Matinas BioPharma Holdings
See all newsBrief: GH Power Signs Multi-Year Hydrogen Offtake Agreement With Change Energy For Hamilton Facility Output
Brief: Gh Power And Tkms Continue To Explore Clean Energy Collaboration In Support Of Canada’S Future Patrol Submarine Project
Brief: Matinas Biopharma - Btig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026 - SEC Filing
Brief: Matinas Biopharma Receives Notice Of Non-Compliance With NYSE American Continued Listing Standards And Acceptance Of Plan To Regain Compliance
Brief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing